The Car and Truck Fleet and Leasing Management Magazine

Trucker Arrested for Illegal Substances in Company Vehicle

April 13, 2009

EL PASO, TX A Texas man was arrested April 8 when an Oregon State Police trooper found marijuana plants, hashish and a kit used for falsifying urine tests during a check of the man's commercial truck, according to The

As part of "Operation Trucker Check," Phillip Mattoon, 53, of El Paso, Texas, pulled the Complete Distribution Services-owned tractor-trailer he was driving into the Woodburn Port of Entry weigh station to be inspected.

A check of the 18-wheeler found the drugs and the kit.

Mattoon was taken into custody and held at the Marion County jail.

He faces charges of operating a commercial motor vehicle while in possession of marijuana, operating a commercial motor vehicle while in possession of hashish, unlawful possession of a controlled substance, unlawful delivery of a controlled substance, unlawful manufacturing of a controlled substance and falsifying a drug-test result.

"Operation Trucker Check" is a 72-hour interagency police and motor-carrier operation that involves inspections of commercial trucks and drivers in the United States, Canada, and Mexico.

Its goals are identifying commercial-vehicle driver and equipment violations, with an emphasis on out-of-service violations; detecting operator impairment by alcohol and/or substance abuse; detecting operator impairment by fatigue; and detecting criminal activity occurring in conjunction with commercial-vehicle operations.

Twitter Facebook Google+


Please note that comments may be moderated. 
Leave this field empty:

Fleet Incentives

Determine the actual cost of owning and running a vehicle in your fleet. Compare vehicles by class and model.


Fleet Tracking And Telematics

Todd Ewing from Fleetmatics will answer your questions and challenges

View All


Fleet Management And Leasing

Merchants Experts will answer your questions and challenges

View All


Sponsored by

Shirley Collins is the U.S. fleet manager at GlaxoSmithKline.

Read more

Up Next

More From The World's Largest Fleet Publisher